Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen Resistant Prostatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07745361
What this trial is testing

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

Who this might be right for
Castration-Resistant Prostate Cancer (CRPC)Castration-Resistant Prostate CancerProstate Cancer+1 more
Monte Rosa Therapeutics, Inc 25
Testing effectiveness (Phase 2)UnknownNCT02254785
What this trial is testing

Cabazitaxel vs Abiraterone or Enzalutamide in Patients With Poor Prognosis Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostatic Cancer
British Columbia Cancer Agency 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06836726
What this trial is testing

Clinical Trial to Test Efficacy of Targeting Hypoxia Combined With ARSI After First-line ARSI Therapy for Castrate Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
University Health Network, Toronto 35
Post-approval studies (Phase 4)Study completedNCT02485691
What this trial is testing

Cabazitaxel Versus the Switch to Alternative AR-targeted Agent (Enzalutamide or Abiraterone) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients Previously Treated With Docetaxel and Who Rapidly Failed a Prior AR-targeted Agent

Who this might be right for
Prostate Cancer Metastatic
Sanofi 255
Early research (Phase 1)Ended earlyNCT05252390
What this trial is testing

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorOvarian CancerOvary Cancer+24 more
Nuvation Bio Inc. 82
Early research (Phase 1)Study completedNCT02924766
What this trial is testing

A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 34
Testing effectiveness (Phase 2)Looking for participantsNCT03522064
What this trial is testing

Bipolar Androgen Therapy + Carboplatin in mCRPC

Who this might be right for
Castration-resistant Prostate CancerHomologous Recombination Deficiency
St Vincent's Hospital, Sydney 30
Very early researchEnded earlyNCT04116164
What this trial is testing

Safety and Targeting of Anti-hk2 Antibody in mCRPC

Who this might be right for
Castration-Resistant Prostatic CancerMetastatic Disease
SpectronRX 27
Not applicableLooking for participantsNCT05647564
What this trial is testing

PET/CT Characterization of Treatment Resistance

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 25
Testing effectiveness (Phase 2)Ended earlyNCT01450683
What this trial is testing

Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapy

Who this might be right for
Prostate CancerProstatic NeoplasmsCastrate-resistant Prostate Cancer (CRPC)+3 more
Stanford University 4
Early research (Phase 1)Looking for participantsNCT06242470
What this trial is testing

MGC026 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorAdvanced CancerMetastatic Cancer+19 more
MacroGenics 250
Testing effectiveness (Phase 2)Study completedNCT01171729
What this trial is testing

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

Who this might be right for
Prostatic Cancer
Samsung Medical Center 12
Early research (Phase 1)Ended earlyNCT03300505
What this trial is testing

ARRx in Combination With Enzalutamide in Metastatic Castration Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT07258407
What this trial is testing

A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer

Who this might be right for
Metastatic Castration-Resistant Prostatic Cancer
T.O.A.D. Oncology SA 180
Testing effectiveness (Phase 2)Looking for participantsNCT06457919
What this trial is testing

Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT04424654
What this trial is testing

Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy

Who this might be right for
Prostate Cancer
Hospital Sirio-Libanes 20
Testing effectiveness (Phase 2)Looking for participantsNCT07226713
What this trial is testing

Pacritinib in Participants With Metastatic Castrate-Resistant Prostate Cancer That Progressed on or After Prior Treatment With Androgen Receptor Signaling Inhibitors

Who this might be right for
Prostate Cancer
Medical College of Wisconsin 32
Testing effectiveness (Phase 2)Looking for participantsNCT06378866
What this trial is testing

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Who this might be right for
Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more
Mayo Clinic 532
Testing effectiveness (Phase 2)Study completedNCT01685983
What this trial is testing

Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 82
Testing effectiveness (Phase 2)Study completedNCT04558866
What this trial is testing

Extreme Bipolar Androgen Therapy With Darolutamide and Testosterone Cypionate in Patients With Metastatic Castration-Resistant Prostate Cancer (ExBAT Trial)

Who this might be right for
Prostate Cancer
Latin American Cooperative Oncology Group 51
Next Page